PRAEVENTIX LLC
Pioneering the future of healthcare by developing innovative therapies for bowel, dermatologic, autoimmune, and neurodegenerative diseases.
Pioneering the future of healthcare by developing innovative therapies for bowel, dermatologic, autoimmune, and neurodegenerative diseases.
Praeventix LLC is an innovative biotechnology startup founded in 2015 with a focus on developing therapies for bowel diseases. The company's slogan, "Pioneering the future of healthcare by developing innovative therapies for bowel, dermatologic, autoimmune, and neurodegenerative diseases," reflects its commitment to addressing diverse medical needs. Praeventix specializes in the discovery, research, and initial clinical development of serotonergic therapeutics with potential applications in dermatologic, autoimmune, and neurodegenerative conditions, in addition to bowel diseases. The company recently secured a significant $4.32M Venture Round investment on 08 November 2022 from Tellus BioVentures. This investment is expected to propel Praeventix's research and development efforts, positioning the startup for potential breakthroughs in treating a range of challenging medical conditions within the Biotechnology, Health Care, and Health and Wellness industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $4.32M | 1 |
|
08 Nov 2022 |
No recent news or press coverage available for PRAEVENTIX LLC.
We care about your data, and we'd love to use cookies make your experience better.
